Report Summary
The global Kidney (Renal) Fibrosis market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Kidney (Renal) Fibrosis market based on company, product type, end user and key regions.
This report studies the global market size of Kidney (Renal) Fibrosis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Kidney (Renal) Fibrosis in these regions.
This research report categorizes the global Kidney (Renal) Fibrosis market by top players/brands, region, type and end user. This report also studies the global Kidney (Renal) Fibrosis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Pfizer
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc.
BioLine Rx Ltd
Genzyme Corporation
Market size by Product
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Market size by End User
Research Center
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Kidney (Renal) Fibrosis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Kidney (Renal) Fibrosis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Kidney (Renal) Fibrosis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Kidney (Renal) Fibrosis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Kidney (Renal) Fibrosis are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Kidney (Renal) Fibrosis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Kidney (Renal) Fibrosis Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by Product
1.4.2 Angiotensin Converting enzyme (ACE) Inhibitors
1.4.3 Pirfenidone
1.4.4 Renin Inhibitors
1.4.5 Angiotensin II Receptor Blockers (ARBs)
1.4.6 Vasopeptidase Inhibitors
1.5 Market by End User
1.5.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by End User
1.5.2 Research Center
1.5.3 Hospital
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Kidney (Renal) Fibrosis Market Size
2.1.1 Global Kidney (Renal) Fibrosis Revenue 2017-2027
2.1.2 Global Kidney (Renal) Fibrosis Sales 2017-2027
2.2 Kidney (Renal) Fibrosis Growth Rate by Regions
2.2.1 Global Kidney (Renal) Fibrosis Sales by Regions
2.2.2 Global Kidney (Renal) Fibrosis Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Kidney (Renal) Fibrosis Sales by Manufacturers
3.1.1 Kidney (Renal) Fibrosis Sales by Manufacturers
3.1.2 Kidney (Renal) Fibrosis Sales Market Share by Manufacturers
3.1.3 Global Kidney (Renal) Fibrosis Market Concentration Ratio (CR5 and HHI)
3.2 Kidney (Renal) Fibrosis Revenue by Manufacturers
3.2.1 Kidney (Renal) Fibrosis Revenue by Manufacturers (2017-2020)
3.2.2 Kidney (Renal) Fibrosis Revenue Share by Manufacturers (2017-2020)
3.3 Kidney (Renal) Fibrosis Price by Manufacturers
3.4 Kidney (Renal) Fibrosis Manufacturing Base Distribution, Product Types
3.4.1 Kidney (Renal) Fibrosis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Kidney (Renal) Fibrosis Product Type
3.4.3 Date of International Manufacturers Enter into Kidney (Renal) Fibrosis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Kidney (Renal) Fibrosis Sales by Product
4.2 Global Kidney (Renal) Fibrosis Revenue by Product
4.3 Kidney (Renal) Fibrosis Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Kidney (Renal) Fibrosis Breakdown Data by End User
6 North America
6.1 North America Kidney (Renal) Fibrosis by Countries
6.1.1 North America Kidney (Renal) Fibrosis Sales by Countries
6.1.2 North America Kidney (Renal) Fibrosis Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Kidney (Renal) Fibrosis by Product
6.3 North America Kidney (Renal) Fibrosis by End User
7 Europe
7.1 Europe Kidney (Renal) Fibrosis by Countries
7.1.1 Europe Kidney (Renal) Fibrosis Sales by Countries
7.1.2 Europe Kidney (Renal) Fibrosis Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Kidney (Renal) Fibrosis by Product
7.3 Europe Kidney (Renal) Fibrosis by End User
8 Asia Pacific
8.1 Asia Pacific Kidney (Renal) Fibrosis by Countries
8.1.1 Asia Pacific Kidney (Renal) Fibrosis Sales by Countries
8.1.2 Asia Pacific Kidney (Renal) Fibrosis Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Kidney (Renal) Fibrosis by Product
8.3 Asia Pacific Kidney (Renal) Fibrosis by End User
9 Central & South America
9.1 Central & South America Kidney (Renal) Fibrosis by Countries
9.1.1 Central & South America Kidney (Renal) Fibrosis Sales by Countries
9.1.2 Central & South America Kidney (Renal) Fibrosis Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Kidney (Renal) Fibrosis by Product
9.3 Central & South America Kidney (Renal) Fibrosis by End User
10 Middle East and Africa
10.1 Middle East and Africa Kidney (Renal) Fibrosis by Countries
10.1.1 Middle East and Africa Kidney (Renal) Fibrosis Sales by Countries
10.1.2 Middle East and Africa Kidney (Renal) Fibrosis Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Kidney (Renal) Fibrosis by Product
10.3 Middle East and Africa Kidney (Renal) Fibrosis by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Merck Kidney (Renal) Fibrosis Products Offered
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Pfizer Kidney (Renal) Fibrosis Products Offered
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Roche Kidney (Renal) Fibrosis Products Offered
11.3.5 Roche Recent Development
11.4 InterMune
11.4.1 InterMune Company Details
11.4.2 Company Business Overview
11.4.3 InterMune Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.4.4 InterMune Kidney (Renal) Fibrosis Products Offered
11.4.5 InterMune Recent Development
11.5 Galectin Therapeutics
11.5.1 Galectin Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Galectin Therapeutics Kidney (Renal) Fibrosis Products Offered
11.5.5 Galectin Therapeutics Recent Development
11.6 La Jolla Pharmaceutical Company
11.6.1 La Jolla Pharmaceutical Company Company Details
11.6.2 Company Business Overview
11.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.6.4 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Products Offered
11.6.5 La Jolla Pharmaceutical Company Recent Development
11.7 ProMetic Life-Sciences Inc.
11.7.1 ProMetic Life-Sciences Inc. Company Details
11.7.2 Company Business Overview
11.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.7.4 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Products Offered
11.7.5 ProMetic Life-Sciences Inc. Recent Development
11.8 BioLine Rx Ltd
11.8.1 BioLine Rx Ltd Company Details
11.8.2 Company Business Overview
11.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.8.4 BioLine Rx Ltd Kidney (Renal) Fibrosis Products Offered
11.8.5 BioLine Rx Ltd Recent Development
11.9 Genzyme Corporation
11.9.1 Genzyme Corporation Company Details
11.9.2 Company Business Overview
11.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Genzyme Corporation Kidney (Renal) Fibrosis Products Offered
11.9.5 Genzyme Corporation Recent Development
12 Future Forecast
12.1 Kidney (Renal) Fibrosis Market Forecast by Regions
12.1.1 Global Kidney (Renal) Fibrosis Sales Forecast by Regions 2021-2027
12.1.2 Global Kidney (Renal) Fibrosis Revenue Forecast by Regions 2021-2027
12.2 Kidney (Renal) Fibrosis Market Forecast by Product
12.2.1 Global Kidney (Renal) Fibrosis Sales Forecast by Product 2021-2027
12.2.2 Global Kidney (Renal) Fibrosis Revenue Forecast by Product 2021-2027
12.3 Kidney (Renal) Fibrosis Market Forecast by End User
12.4 North America Kidney (Renal) Fibrosis Forecast
12.5 Europe Kidney (Renal) Fibrosis Forecast
12.6 Asia Pacific Kidney (Renal) Fibrosis Forecast
12.7 Central & South America Kidney (Renal) Fibrosis Forecast
12.8 Middle East and Africa Kidney (Renal) Fibrosis Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Kidney (Renal) Fibrosis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
